1. Home
  2. EQBK vs ARDX Comparison

EQBK vs ARDX Comparison

Compare EQBK & ARDX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Equity Bancshares Inc.

EQBK

Equity Bancshares Inc.

N/A

Current Price

$48.83

Market Cap

982.9M

Sector

Finance

ML Signal

N/A

Logo Ardelyx Inc.

ARDX

Ardelyx Inc.

N/A

Current Price

$2.99

Market Cap

797.8M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
EQBK
ARDX
Founded
2002
2007
Country
United States
United States
Employees
N/A
N/A
Industry
Major Banks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
982.9M
797.8M
IPO Year
2015
2014

Fundamental Metrics

Financial Performance
Metric
EQBK
ARDX
Price
$48.83
$2.99
Analyst Decision
Buy
Strong Buy
Analyst Count
7
11
Target Price
★ $54.14
$12.80
AVG Volume (30 Days)
110.7K
★ 4.0M
Earning Date
10-14-2026
11-03-2026
Dividend Yield
★ 1.80%
N/A
EPS Growth
N/A
★ N/A
EPS
★ 2.06
N/A
Revenue
N/A
★ $2,607,000.00
Revenue This Year
$29.42
$19.60
Revenue Next Year
$21.36
$28.11
P/E Ratio
$23.73
★ N/A
Revenue Growth
★ N/A
N/A
52 Week Low
$39.98
$2.99
52 Week High
$52.27
$8.40

Technical Indicators

Market Signals
Indicator
EQBK
ARDX
Relative Strength Index (RSI) 56.93 32.91
Support Level $48.53 N/A
Resistance Level $48.80 $3.35
Average True Range (ATR) 1.14 0.13
MACD 0.30 0.00
Stochastic Oscillator 75.75 2.67

Price Performance

Historical Comparison
EQBK
ARDX

About EQBK Equity Bancshares Inc.

Equity Bancshares Inc is a bank holding company. It provides a broad range of financial services to businesses and business owners as well as individuals through network of nearly 77 branches located in Arkansas, Kansas, Missouri and Oklahoma. The majority of the Company's revenues come from interest income on financial instruments, including loans, leases, securities and derivatives. The company also earns revenue from Non-interest income which includes Service charges and fees, Debit card income, Investment Referral Income, Trust Income and Insurance Sales Commissions.

About ARDX Ardelyx Inc.

Ardelyx Inc is a biopharmaceutical company developing and commercialize, first-in-class medicines that meet unmet medical needs. It has developed a platform that enabled the discovery of new biological mechanisms and pathways to develop potent and efficacious therapies that minimize the side effects and drug-drug interactions frequently encountered with traditional, systemically absorbed medicines. Its products Tenapanor, branded as IBSRELA, is used for the treatment of adults with IBS-C. Tenapanor, branded as XPHOZAH, is used to reduce serum phosphorus in adults with CKD on dialysis as add-on therapy in patients who have an inadequate response to phosphate binders or who are intolerant of any dose of phosphate binder therapy.

Share on Social Networks: